• Latest Posts

New therapy transitions toxic immune cells from harmful to healing to fight effects of hyperinflammation in children

A biotech boom manifesting real results in rare pediatric diseases

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

More News! 10 Nov 2022

Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing

ADVERTISEMENT

Avstera receives funding for cancer programs

Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment

More News! 9 Nov 2022

Sensorium closes $30M deal to advance drug discovery engine

GHO Capital and Vistria Group to acquire CDMO Alcami

Vir Biotech presents new data for functional cure of chronic Hep B virus

MedinCell’s partner AIC registers trial for drug for total knee replacement pain

ADVERTISEMENT